Andrew Plump

Board Member, Chief Scientific and Medical Officer, Takeda Pharmaceuticals International Inc.

Bachelor's degree, MIT; MD, University of California, San Francisco; PhD, Rockefeller University. Formerly: Senior Vice-President, Research & Translational Medicine, Deputy to the President of R&D, Sanofi; Vice-President, Worldwide Cardiovascular Research Head, Merck. Chief Medical and Scientific Officer and R&D Head, Takeda, leading drug discovery and development across Takeda’s core therapeutic areas, which include oncology, gastroenterology, CNS, cardiometabolic and vaccines.

About us

Engage with us

Quick links

Language editions

Privacy Policy & Terms of Service

Sitemap

© 2025 World Economic Forum